Healthequity (HQY) Fundamental Analysis: Revenue, Earnings & Valuation

8.57 / 10

Outperform

Fundamentals score 8.6/10, rated Outperform. Key strengths include Cash‑MV, Net cash flow per share, Asset‑MV, and high earnings‑per‑share growth (≈70%). Weak spots are PB‑ROE and Revenue‑MV, which lag. Overall, the company shows excellent financial health.

Analysis Checks(7/10)

Revenue-MV

Value-0.11

Score0/3

Weight-10.81%

1M Return-6.46%

Net cash flow from operating activities per share (YoY growth rate %)

Value39.30

Score3/3

Weight14.29%

1M Return5.35%

PB-ROE

Value1.27

Score0/3

Weight-2.25%

1M Return-1.30%

Basic earnings per share (YoY growth rate %)

Value70.77

Score3/3

Weight11.97%

1M Return4.72%

Total profit (YoY growth rate %)

Value54.63

Score3/3

Weight12.88%

1M Return5.14%

Net cash flow from operating activities (YoY growth rate %)

Value39.96

Score3/3

Weight14.56%

1M Return5.57%

Cash-UP

Value-0.15

Score1/3

Weight1.50%

1M Return0.66%

Diluted earnings per share (YoY growth rate %)

Value70.31

Score3/3

Weight12.70%

1M Return5.00%

Asset-MV

Value-0.55

Score3/3

Weight26.50%

1M Return9.13%

Cash-MV

Value0.57

Score3/3

Weight18.66%

1M Return6.61%

Is HQY fundamentally strong?

HQY scores 8.57/10 on fundamentals and holds a Discounted valuation at present. Backed by its 10.19% ROE, 16.38% net margin, 32.39 P/E ratio, 3.31 P/B ratio, and 125.23% earnings growth, these metrics solidify its Outperform investment rating.